Novavax Inc financial data

Symbol
NVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Quince Orchard Road, Gaithersburg, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 80.6 % +10.7%
Quick Ratio 2.69 % +16.4%
Debt-to-equity -346 % +7.01%
Return On Equity 43.7 % -46.9%
Return On Assets -17.8 % +41.3%
Operating Margin -29.7 % +24.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 160M shares +69.6%
Common Stock, Shares, Outstanding 160M shares +69.5%
Entity Public Float 699M USD -82.6%
Common Stock, Value, Issued 1.61M USD +69.4%
Weighted Average Number of Shares Outstanding, Basic 148M shares +66%
Weighted Average Number of Shares Outstanding, Diluted 166M shares +59.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 988M USD -38.2%
Cost of Revenue 359M USD -49.1%
Research and Development Expense 471M USD -54.3%
General and Administrative Expense 451M USD -8.15%
Costs and Expenses 1.28B USD -42.5%
Operating Income (Loss) -293M USD +53.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -289M USD +50.7%
Income Tax Expense (Benefit) 5.46M USD +336%
Net Income (Loss) Attributable to Parent -294M USD +49.8%
Earnings Per Share, Basic -2.61 USD/shares +64.3%
Earnings Per Share, Diluted -2.64 USD/shares +63.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 680M USD +34.4%
Marketable Securities, Current 369M USD
Inventory, Net 9.17M USD -61%
Other Assets, Current 156M USD +104%
Assets, Current 1.2B USD +6.72%
Property, Plant and Equipment, Net 289M USD -3.8%
Operating Lease, Right-of-Use Asset 25M USD -31.3%
Intangible Assets, Net (Excluding Goodwill) 8.46M USD +68.2%
Goodwill 123M USD -3.89%
Other Assets, Noncurrent 33.8M USD +1.19%
Assets 1.82B USD +7.93%
Accounts Payable, Current 80M USD -8.35%
Employee-related Liabilities, Current 56M USD +6.44%
Accrued Liabilities, Current 159M USD -65.3%
Contract with Customer, Liability, Current 666M USD +122%
Liabilities, Current 1.16B USD -27.5%
Contract with Customer, Liability, Noncurrent 533M USD -12.1%
Operating Lease, Liability, Noncurrent 28.6M USD -42.9%
Other Liabilities, Noncurrent 335M USD +774%
Liabilities 2.25B USD -7.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.5M USD -28.5%
Retained Earnings (Accumulated Deficit) -4.81B USD -6.52%
Stockholders' Equity Attributable to Parent -432M USD +42.8%
Liabilities and Equity 1.82B USD +7.93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -83.6M USD +74.3%
Net Cash Provided by (Used in) Financing Activities 5.89M USD
Net Cash Provided by (Used in) Investing Activities -7.25M USD +69.2%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 161M shares +69.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -87.9M USD +87.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 696M USD +34.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.21M USD -81.6%
Deferred Tax Assets, Valuation Allowance 1.13B USD +10.7%
Deferred Tax Assets, Gross 1.19B USD +12.3%
Operating Lease, Liability 113M USD -10.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -297M USD +49.2%
Lessee, Operating Lease, Liability, to be Paid 161M USD +7.44%
Property, Plant and Equipment, Gross 381M USD +11.5%
Operating Lease, Liability, Current 23M USD +36.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.2M USD -30.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 34.4M USD -27.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 48.2M USD +98.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.6M USD +30.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 4.24M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14M USD +33.2%
Additional Paid in Capital 4.48B USD +16.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 57.9M USD +57.7%
Share-based Payment Arrangement, Expense 62.1M USD -42.7%
Interest Expense 14.2M USD -26.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%